Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 33 6
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021 4 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/19/2021 6 2
Taxifolin Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020 2 0
GD1-69 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
Luminol sodium salt Potential treatment - pre-clinical evidence Experimental Antiviral Nov/20/2020 1 0
Prednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/14/2020 4 0